Cargando…
Enhancement of Mitochondrial Function by the Neurogenic Molecule NSI-189 Accompanies Reversal of Peripheral Neuropathy and Memory Impairment in a Rat Model of Type 2 Diabetes
AIMS: Mitochondrial dysfunction contributes to many forms of peripheral and central nervous system degeneration. Therapies that protect mitochondrial number and function have the potential to impact the progression of conditions such as diabetic neuropathy. We therefore assessed indices of mitochond...
Autores principales: | Jolivalt, C. G., Aghanoori, M. R., Navarro-Diaz, M. C., Han, M. M., Sanchez, G., Guernsey, L., Quach, D., Johe, K., Fernyhough, P., Calcutt, N. A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372526/ https://www.ncbi.nlm.nih.gov/pubmed/35967127 http://dx.doi.org/10.1155/2022/8566970 |
Ejemplares similares
-
NSI‐189, a small molecule with neurogenic properties, exerts behavioral, and neurostructural benefits in stroke rats
por: Tajiri, Naoki, et al.
Publicado: (2017) -
A phase 2, double-blind, placebo-controlled study of NSI-189 phosphate, a neurogenic compound, among outpatients with major depressive disorder
por: Papakostas, G. I., et al.
Publicado: (2019) -
A Phase 1B, randomized, double blind, placebo controlled, multiple-dose escalation study of NSI-189 phosphate, a neurogenic compound, in depressed patients
por: Fava, M, et al.
Publicado: (2016) -
Erratum: A Phase 1B, randomized, double blind, placebo controlled, multiple-dose escalation study of NSI-189 phosphate, a neurogenic compound, in depressed patients
por: Fava, M, et al.
Publicado: (2016) -
Behavioral and Histopathological Assessment of Adult Ischemic Rat Brains after Intracerebral Transplantation of NSI-566RSC Cell Lines
por: Tajiri, Naoki, et al.
Publicado: (2014)